Economic burden of cardiovascular disease in the United Kingdom.

ABSTRACT:

Background and aims

Direct (medical and non-medical) and indirect (production losses and informal care) costs of cardiovascular disease (CVD) have been captured in two previous United Kingdom (UK) cost-of-illness studies, but the areas of long-term care and medical device costs were neglected. We aimed to quantify the economic burden of CVD in the UK from a societal perspective between the fiscal years 2019/20 and 2021/22.

Methods and results

Mixed-methods study in a prevalence-based retrospective review of economic costs focused on the public sector. Top-down costing was applied to the following areas: inpatient hospital care, outpatient specialist care, emergency care, primary care, medications, medical devices, long-term care, production losses to morbidity, and productio

SUBMITTER: Shih K 

PROVIDER: S-EPMC12342905 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature